SFDA To Confirm Registrations For All Injectable Drugs
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State Food and Drug Administration will review the registrations of all injectable drugs during the next ten months, and drugs whose manufacturing processes are not in line with their registration documents will have to halt production until the new processes are approved, under a notice issued Aug. 20